INM logo

InMed Pharmaceuticals (INM)

Profile

Full Name

InMed Pharmaceuticals Inc.

Ticker Symbol

INM

Exchange

NASDAQ

Country

Canada

IPO

May 5, 2014

Indexes

Not included

Employees

13

Key Details

Price

$2.67(-3.99%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.60M(+11.17% YoY)

Annual EPS

-$20.20(+68.92% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Dec 22, 21 HC Wainwright & Co.
Buy
Nov 29, 21 HC Wainwright & Co.
Buy
Feb 16, 21 Roth Capital
Buy

Institutional Ownership

  • What is the ticker symbol for InMed Pharmaceuticals?
  • Does InMed Pharmaceuticals pay dividends?
  • What sector is InMed Pharmaceuticals in?
  • What industry is InMed Pharmaceuticals in?
  • What country is InMed Pharmaceuticals based in?
  • When did InMed Pharmaceuticals go public?
  • Is InMed Pharmaceuticals in the S&P 500?
  • Is InMed Pharmaceuticals in the NASDAQ 100?
  • Is InMed Pharmaceuticals in the Dow Jones?
  • When was InMed Pharmaceuticals's last earnings report?
  • When does InMed Pharmaceuticals report earnings?
  • Should I buy InMed Pharmaceuticals stock now?

What is the ticker symbol for InMed Pharmaceuticals?

The ticker symbol for InMed Pharmaceuticals is NASDAQ:INM

Does InMed Pharmaceuticals pay dividends?

No, InMed Pharmaceuticals does not pay dividends

What sector is InMed Pharmaceuticals in?

InMed Pharmaceuticals is in the Healthcare sector

What industry is InMed Pharmaceuticals in?

InMed Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is InMed Pharmaceuticals based in?

InMed Pharmaceuticals is headquartered in Canada

When did InMed Pharmaceuticals go public?

InMed Pharmaceuticals's initial public offering (IPO) was on May 5, 2014

Is InMed Pharmaceuticals in the S&P 500?

No, InMed Pharmaceuticals is not included in the S&P 500 index

Is InMed Pharmaceuticals in the NASDAQ 100?

No, InMed Pharmaceuticals is not included in the NASDAQ 100 index

Is InMed Pharmaceuticals in the Dow Jones?

No, InMed Pharmaceuticals is not included in the Dow Jones index

When was InMed Pharmaceuticals's last earnings report?

InMed Pharmaceuticals's most recent earnings report was on Feb 12, 2025

When does InMed Pharmaceuticals report earnings?

The next expected earnings date for InMed Pharmaceuticals is May 14, 2025

Should I buy InMed Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page